OCELD Projected Dividend Yield
Organicell Regenerative Medicine Inc ( OTCBB : OCELD )Organicell Regenerative Medicine is a clinical-stage biopharmaceutical company, principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. Co.'s proprietary products are derived from perinatal sources and are principally used in the health care industry administered through doctors and clinics. Co.'s primary product, Zofin™ (Organicell™ Flow) is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. 20 YEAR PERFORMANCE RESULTS |
OCELD Dividend History Detail OCELD Dividend News OCELD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |